Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Clinical trial NCT06819228 · RECRUITING

Trial details

NCT number: NCT06819228
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HNSCC HNSCC,Larynx, Pharynx and Oral Cavity SCC - Squamous Cell Carcinoma

Start date: 2025-04-17
Primary completion: 2028-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.